跳至主要内容
临床试验/NCT01829230
NCT01829230已完成不适用

Myopia Progression After Ceasing Myopia Control Contact Lens Wear

Johnson & Johnson Vision Care, Inc.1 个研究点 分布在 1 个国家目标入组 82 人开始时间: 2010年3月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
82
试验地点
1
主要终点
Spherical Equivalent Refractive Error

研究概览

简要总结

This is a continuation study for subjects who were previously fit with test or control lenses; all will stop wearing their study lenses assigned in the previous study and will start to wear an FDA-approved marketed spherical soft contact lens.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
9 Years 至 13 Years(Child)
性别
All
接受健康志愿者

入选标准

  • The subject must be enrolled in the parent protocol for at least one year.
  • The subject's parent or legal guardian must read and sign the STATEMENT OF INFORMED CONSENT and the subject must read and sign the Child's Assent Form and be provided a copy of each form.
  • The subject must appear able and willing to adhere to the instructions set forth in this clinical protocol.

排除标准

  • Ocular or systemic allergies that may interfere with contact lens wear.
  • Systemic disease or autoimmune disease or use of medication (e.g. antihistamine), which may interfere with contact lens wear.
  • Clinically significant (grade 3 or 4) corneal edema, corneal vascularization, corneal staining or any other abnormality of the cornea, which may contraindicate contact lens wear.
  • Clinically significant (grade 3 or 4) tarsal abnormalities or bulbar injection that might interfere with contact lens wear.
  • Any ocular infection.
  • Any corneal distortion resulting from previous hard or rigid gas permeable contact lens wear.
  • Any infectious disease (e.g. hepatitis, tuberculosis) or an immunosuppressive disease (e.g. HIV)
  • Previous refractive surgery, orthokeratology, keratoconus, or other corneal irregularity in either eye. Rigid contact lens wearers cannot be enrolled in the study.
  • Strabismus.
  • Pupil or lid abnormality or infection in either eye
  • Central corneal scar in either eye
  • Aphakia in either eye
  • Contraindications to contact lens wear such as dry eye or history of prior unsuccessful contact lens wear.
  • History of participation in prior clinical trials aimed to control myopia progression, except for the parent trial
  • Surgically altered eyes, ocular infection of any type, ocular inflammation.
  • Anterior chamber angle grade 2 or narrower by Van Herrick method.

研究组 & 干预措施

Test lens C

Experimental

Test lens C from previous study

干预措施: 1 Day Acuvue Moist (Device)

Test lens A

Active Comparator

Test lens A from previous study

干预措施: 1 Day Acuvue Moist (Device)

结局指标

主要结局

Spherical Equivalent Refractive Error

时间窗: Baseline and every 6 months up to 18 months

Cycloplegic spherical equivalent refraction of the subjects's right eye was computed from the sphero-cylindrical refraction measured with an open-field auto refractor. The median of 5 repeated measurements, each of which was the average of 3 consecutive readings, was used for the analysis.

Axial Length of the Eye

时间窗: Baseline and every 6 months post-baseline up to 18 months

Axial length was measured with the IOLMaster at baseline and then every 6 months throughout the course of the study. Five measurements were collected at each visit from the subject's right eye and the average of the 5 measurements was used for the analysis.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Myopia Progression After Ceasing Myopia Control... | 临床试验